Brilliant find mate. Thanks for sharing.
"The ongoing Covid-19 pandemic highlights the critical need for rapid development of vaccines and antiviral treatments to reduce the number of hospitalizations and deaths caused by this dangerous new coronavirus, SARS-CoV-2. The biopharmaceutical industry has quickly responded and at least 80 candidates are already in development. With good luck, we will eventually have some of the tools we need to fight this new global threat.
But there is an even larger threat lurking behind the current outbreak, one that is already killing hundreds of thousands of people around the world and that will complicate the care of many Covid-19 patients. It is the hidden threat from antibiotic resistance — bacteria that are not killed by standard antibiotics. Unfortunately, the pipeline of drugs to manage these deadly infections is nearly dry."
"nearly dry."
But not completely, thanks to companies like ours (if BTX1801 is confirmed as a winner)
- Forums
- ASX - By Stock
- Ann: Antimicrobial Platform Update and Launch of BTX 1801 Study
Brilliant find mate. Thanks for sharing. "The ongoing Covid-19...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
27.5¢ |
Change
0.025(10.0%) |
Mkt cap ! $433.1M |
Open | High | Low | Value | Volume |
25.5¢ | 27.5¢ | 25.5¢ | $2.544M | 9.500M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 4450 | 27.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
27.5¢ | 1310144 | 21 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 4450 | 0.270 |
4 | 150870 | 0.265 |
9 | 405996 | 0.260 |
7 | 497071 | 0.255 |
28 | 1443883 | 0.250 |
Price($) | Vol. | No. |
---|---|---|
0.275 | 1310144 | 21 |
0.280 | 1583338 | 10 |
0.285 | 52400 | 2 |
0.290 | 320000 | 4 |
0.295 | 60169 | 3 |
Last trade - 16.10pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
27.0¢ |
  |
Change
0.025 ( 8.04 %) |
|||
Open | High | Low | Volume | ||
25.5¢ | 27.5¢ | 25.5¢ | 12615285 | ||
Last updated 15.59pm 06/05/2024 ? |
Featured News
BOT (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online